Lim HY - Search Results

1

Increased Risk of Young-Onset Digestive Tract Cancers Among Young Adults Age 20-39 Years With Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study.

Park JH, Hong JY, Shen JJ, Han K, Park JO, Park YS, Lim HY. Park JH, et al. Among authors: lim hy. J Clin Oncol. 2023 Jun 20;41(18):3363-3373. doi: 10.1200/JCO.22.01740. Epub 2023 Apr 19. J Clin Oncol. 2023. PMID: 37075279

2

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.

Park KW, Ahn JS, Park YS, Lee J, Kang JH, Park JO, Lim HY, Im YH, Kang WK, Park K, Lee SI. Park KW, et al. Among authors: lim hy. Cancer Chemother Pharmacol. 2007 Jan;59(1):17-21. doi: 10.1007/s00280-006-0253-2. Epub 2006 May 24. Cancer Chemother Pharmacol. 2007. PMID: 16721549 Clinical Trial.

3

Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.

Lee J, Kang WK, Kwon JM, Oh SY, Lee HR, Kim HJ, Park BB, Lim HY, Han MJ, Park JO, Park YS. Lee J, et al. Among authors: lim hy. Ann Oncol. 2007 Jan;18(1):88-92. doi: 10.1093/annonc/mdl317. Epub 2006 Sep 13. Ann Oncol. 2007. PMID: 16971670 Free article. Clinical Trial.

4

Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.

Hong YS, Lee J, Lee SC, Hwang IG, Choi SH, Heo JS, Park JO, Park YS, Lim HY, Kang WK. Hong YS, et al. Among authors: lim hy. Cancer Chemother Pharmacol. 2007 Aug;60(3):321-8. doi: 10.1007/s00280-006-0380-9. Epub 2006 Dec 2. Cancer Chemother Pharmacol. 2007. PMID: 17143602 Clinical Trial.

5

Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma.

Lee J, Lim T, Uhm JE, Park KW, Park SH, Lee SC, Park JO, Park YS, Lim HY, Sohn TS, Noh JH, Heo JS, Park CK, Kim S, Kang WK. Lee J, et al. Among authors: lim hy, lim t. Ann Oncol. 2007 May;18(5):886-91. doi: 10.1093/annonc/mdl501. Epub 2007 Feb 13. Ann Oncol. 2007. PMID: 17298958 Free article.

6

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma.

Lee J, Jang KT, Ki CS, Lim T, Park YS, Lim HY, Choi DW, Kang WK, Park K, Park JO. Lee J, et al. Among authors: lim hy, lim t. Cancer. 2007 Apr 15;109(8):1561-9. doi: 10.1002/cncr.22559. Cancer. 2007. PMID: 17354229 Free article.

7

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma.

Park BB, Park JO, Lee HR, Lee J, Choi DW, Choi SH, Heo JS, Lee JK, Lee KT, Lim DH, Park YS, Lim HY, Kang WK, Park K. Park BB, et al. Among authors: lim dh, lim hy. Cancer Chemother Pharmacol. 2007 Sep;60(4):489-94. doi: 10.1007/s00280-006-0390-7. Epub 2007 Mar 30. Cancer Chemother Pharmacol. 2007. PMID: 17396266 Clinical Trial.

8

Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer.

Lee J, Im YH, Lee SH, Cho EY, Choi YL, Ko YH, Kim JH, Nam SJ, Kim HJ, Ahn JS, Park YS, Lim HY, Han BK, Yang JH. Lee J, et al. Among authors: lim hy. Cancer Chemother Pharmacol. 2008 Apr;61(4):569-77. doi: 10.1007/s00280-007-0506-8. Epub 2007 May 17. Cancer Chemother Pharmacol. 2008. PMID: 17508214 Clinical Trial.

9

Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer.

Park S, Ahn MJ, Ahn JS, Lee J, Hong YS, Park BB, Lee SC, Hwang IG, Park JO, Lim H, Kang WK, Park K. Park S, et al. Lung Cancer. 2007 Oct;58(1):116-22. doi: 10.1016/j.lungcan.2007.05.022. Epub 2007 Jul 12. Lung Cancer. 2007. PMID: 17624473

10

Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy.

Lee J, Park CK, Park JO, Lim T, Park YS, Lim HY, Lee I, Sohn TS, Noh JH, Heo JS, Kim S, Lim DH, Kim KM, Kang WK. Lee J, et al. Among authors: lim dh, lim hy, lim t. Clin Cancer Res. 2008 Jan 1;14(1):82-8. doi: 10.1158/1078-0432.CCR-07-0612. Clin Cancer Res. 2008. PMID: 18172256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

650 results

Search Page